PT Kalbe Farma Tbk. (PTKFF)
OTCMKTS
· Delayed Price · Currency is USD
0.0951
0.00 (0.00%)
At close: Nov 12, 2024
PT Kalbe Farma Tbk. Revenue
PT Kalbe Farma Tbk. had revenue of 7.91T IDR in the quarter ending September 30, 2024, with 7.16% growth. This brings the company's revenue in the last twelve months to 32.13T, up 5.98% year-over-year. In the year 2023, PT Kalbe Farma Tbk. had annual revenue of 30.45T with 5.24% growth.
Revenue (ttm)
32.13T IDR
Revenue Growth
+5.98%
P/S Ratio
n/a
Revenue / Employee
2.45B IDR
Employees
13,108
Market Cap
3.99B USD
Revenue Chart
* This company reports financials in IDR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 30.45T | 1,515.63B | 5.24% |
Dec 31, 2022 | 28.93T | 2,672.31B | 10.18% |
Dec 31, 2021 | 26.26T | 3,148.54B | 13.62% |
Dec 31, 2020 | 23.11T | 479.18B | 2.12% |
Dec 31, 2019 | 22.63T | 1,559.17B | 7.40% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.66B |
Ryman Healthcare Limited | 458.44M |
Verano Holdings Corp. | 897.57M |
Vireo Growth Inc. | 98.53M |
Medexus Pharmaceuticals Inc. | 104.76M |